426 results on '"Verstraete, Alain G"'
Search Results
2. Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients
3. Pilot study of oral fluid and plasma meropenem and piperacillin concentrations in the intensive care unit
4. Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS method
5. Development, validation and application of an inductively coupled plasma – mass spectrometry method to determine cobalt in metal-on-metal prosthesis patients using volumetric absorptive microsampling
6. Subtherapeutic piperacillin concentrations in neurocritical patients
7. Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on Two Routine Chemistry Analyzers
8. Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy
9. Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study
10. Development and validation of an ultra-high performance liquid chromatography – high resolution mass spectrometry method for the quantification of total and free teicoplanin in human plasma
11. Automation in Microsampling
12. Pretomanid-resistant tuberculosis
13. Δ9-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects following cannabis intake – A pilot study using illicit cannabis
14. Measuring Unbound Versus Total Piperacillin Concentrations in Plasma of Critically Ill Patients: Methodological Issues and Relevance
15. Pretomanid-resistant tuberculosis
16. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood
17. Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review
18. Identification of etazene (etodesnitazene) metabolites in human urine by LC‐HRMS
19. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay
20. Prescribing and dispensing guidelines for medicinal drugs affecting driving performance
21. Proficiency Testing for Meropenem and Piperacillin Therapeutic Drug Monitoring: Preliminary Results From the Belgian Society on Infectiology and Clinical Microbiology Pharmacokinetic–Pharmacodynamic Working Group
22. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood
23. The Results of the Roadside Drug Testing Assessment Project
24. Analytical performance of eight enzymatic assays for ethanol in serum evaluated by data from the Belgian external quality assessment scheme
25. Random and systematic errors in case–control studies calculating the injury risk of driving under the influence of psychoactive substances
26. Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur).
27. Repeatability of oral fluid collection methods for THC measurement
28. Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method
29. Prevalence of alcohol and other psychoactive substances in injured drivers: Comparison between Belgium and the Netherlands
30. Prevalence and Risk of Injury in Europe by Driving with Alcohol, Illicit Drugs and Medicines
31. Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome
32. Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry Analyzers
33. Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples
34. Identification of etazene (etodesnitazene) metabolites in human urine by LC‐HRMS.
35. Impaired hemoglobin scavenging during an acute HIV-1 retroviral syndrome
36. Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces
37. Exploration of the pre-analytical stability of β-lactam antibiotics in plasma and blood - implications for therapeutic drug monitoring and pharmacokinetic studies
38. Therapeutic drug monitoring of voriconazole: validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography
39. The toxicological challenges in the European research project DRUID
40. The modern trends in alcohol, drugs and driving research
41. Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care.
42. Effects of alcohol (BAC 0.5‰) and ecstasy (MDMA 100 mg) on simulated driving performance and traffic safety
43. Medicines and driving: evaluation of training and software support for patient counselling by pharmacists
44. Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures
45. Multicenter method evaluation of the ARK™ Methotrexate Immunoassay
46. A sensitive and high‐throughput quantitative liquid chromatography high‐resolution mass spectrometry method for therapeutic drug monitoring of 10 β ‐lactam antibiotics, linezolid and two β ‐lactamase inhibitors in human plasma
47. Long‐term chemogenetic suppression of seizures in a multifocal rat model of temporal lobe epilepsy
48. Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)
49. Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care
50. Development and validation of a liquid chromatography--tandem mass spectrometry assay for the quantification of docetaxel and paclitaxel in human plasma and oral fluid
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.